MK

Mukeshbhai Kanubhai Pokiya

Active Director Director DIN 08302391
DIN 08302391 First appointment Dec 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value •••• Premium profile

About Mukeshbhai Kanubhai Pokiya

Data last updated:

Mukeshbhai Kanubhai Pokiya is a Director at Axelus Pharma Private Limited (since 2018). The company operates in Pharma. Axelus Pharma Private Limited reported revenue of ₹3.45 Cr (FY 2025).

DIN 08302391
Primary Designation Director
Industry Pharma
First Appointment 12 Dec 2018
Oldest Company Age 7 yrs
Largest company Axelus Pharma Private Limited · ₹3.45 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Axelus Pharma Private Limited U24239GJ2018PTC105580
Director12 Dec 20182018₹3.45 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Axelus Pharma Private Limited
Premium access

Shareholding and investment profile for Mukeshbhai Kanubhai Pokiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukeshbhai Kanubhai Pokiya

Mukeshbhai Kanubhai Pokiya currently holds 1 directorship: Axelus Pharma Private Limited (Director, since 12 Dec 2018, revenue ₹3.45 Cr (FY 2025)).

Mukeshbhai Kanubhai Pokiya was first appointed on 12 Dec 2018 as Director at Axelus Pharma Private Limited.

The current boards of Mukeshbhai Kanubhai Pokiya's companies include Bhailalbhai Khodabhai Bhesaniya (Axelus Pharma Private Limited), Dhavalkumar Maganbhai Dobariya (Axelus Pharma Private Limited), Ghanshyambhai Manubhai Bhesaniya (Axelus Pharma Private Limited), Haribhai Popatbhai Kukadiya (Axelus Pharma Private Limited), Rajeshbhai Dhirajlal Devani (Axelus Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available